Search Results

Filter
  • 1-10 of  93,427 results for "%22IMMUNOSUPPRESSION%22"
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Complete tumor resection reverses neutrophilia-associated suppression of systemic anti-tumor immunity.

  • Authors : Kaskas A; Surgical Oncology Program, Center For Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Clavijo P

Subjects: Proteomics* ; Immunosuppression Therapy*; Animals

  • Source: Oral oncology [Oral Oncol] 2024 Mar; Vol. 150, pp. 106705. Date of Electronic Publication: 2024 Jan 26.Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593

Record details

×
Academic Journal

Persistent inflammation, immunosuppression, and catabolism syndrome (PICS): a review of definitions, potential therapies, and research priorities.

  • Authors : Chadda KR; William Harvey Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK; Homerton College, University of Cambridge, Cambridge, UK

Subjects: Critical Illness* ; Immunosuppression Therapy*/Immunosuppression Therapy*/Immunosuppression Therapy*/adverse effects; Animals

  • Source: British journal of anaesthesia [Br J Anaesth] 2024 Mar; Vol. 132 (3), pp. 507-518. Date of Electronic Publication: 2024 Jan 04.Publisher: Elsevier Country of Publication: England NLM ID: 0372541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-6771

Record details

×
Academic Journal

Systemic inflammatory response syndrome triggered by blood-borne pathogens induces prolonged dendritic cell paralysis and immunosuppression.

  • Authors : Ashayeripanah M; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC 3000, Australia.; Vega-Ramos J

Subjects: Blood-Borne Pathogens* ; Immunosuppression Therapy*; Humans

  • Source: Cell reports [Cell Rep] 2024 Feb 27; Vol. 43 (2), pp. 113754. Date of Electronic Publication: 2024 Feb 13.Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Prevalence of Immunosuppression Among US Adults.

Subjects: Immunosuppression Therapy*/Immunosuppression Therapy*/Immunosuppression Therapy*/statistics & numerical data ; Immunocompromised Host*; Health Surveys

  • Source: JAMA [JAMA] 2024 Mar 12; Vol. 331 (10), pp. 880-882.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Remission definitions guiding immunosuppressive therapy in rheumatoid arthritis: which is best fitted for the purpose?

  • Authors : Duarte C; Department of Rheumatology, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal.; Institute for Clinical and Biomedical Research, University of Coimbra, Coimbra, Portugal.

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/diagnosis ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Immunosuppression Therapy*

  • Source: RMD open [RMD Open] 2024 Mar 04; Vol. 10 (1). Date of Electronic Publication: 2024 Mar 04.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Characterization of the MT-2 Treg-like cell line in the presence and absence of forkhead box P3 (FOXP3).

  • Authors : McCullough MJ; Division of Pulmonary Diseases and Critical Care Medicine, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.; Marsico Lung Institute, University of North Carolina, Chapel Hill, NC, USA.

Subjects: T-Lymphocytes, Regulatory* ; Immunosuppression Therapy*; Humans

  • Source: Immunology and cell biology [Immunol Cell Biol] 2024 Mar; Vol. 102 (3), pp. 211-224. Date of Electronic Publication: 2024 Jan 30.Publisher: Wiley Country of Publication: United States NLM ID: 8706300 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1711

Record details

×
Academic Journal

The relationship between histopathological features, immunosuppression and outcome in patients undergoing native kidney biopsies.

  • Authors : Kipgen D; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK.; Crosby J

Subjects: Immunosuppression Therapy* ; Kidney Diseases*/Kidney Diseases*/Kidney Diseases*/pathology; Adult

  • Source: Histopathology [Histopathology] 2024 Mar; Vol. 84 (4), pp. 671-682. Date of Electronic Publication: 2023 Dec 12.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7704136 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Conversion from calcineurin inhibitors to belatacept-based immunosuppressive therapy skews terminal proliferation of non-classical monocytes and lowers lymphocyte counts.

  • Authors : Bredewold OW; Department of Internal Medicine (Nephrology) and the Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, the Netherlands.. Electronic address: .; van Oeveren-Rietdijk AM

Subjects: Abatacept*/Abatacept*/Abatacept*/therapeutic use ; Calcineurin Inhibitors*/Calcineurin Inhibitors*/Calcineurin Inhibitors*/therapeutic use ; Immunosuppression Therapy*/Immunosuppression Therapy*/Immunosuppression Therapy*/methods

  • Source: Transplant immunology [Transpl Immunol] 2024 Feb; Vol. 82, pp. 101976. Date of Electronic Publication: 2024 Jan 08.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9309923 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A bioengineered artificial interstitium supports long-term islet xenograft survival in nonhuman primates without immunosuppression.

Subjects: Immunosuppression Therapy* ; Primates*; Adult

  • Source: Science advances [Sci Adv] 2024 Jan 05; Vol. 10 (1), pp. eadi4919. Date of Electronic Publication: 2024 Jan 05.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic

Record details

×
Academic Journal

Minimization of Transplant Immunosuppression: An Elusive Goal.

  • Authors : Lee BK; Division of Nephrology, Department of Medicine, Dell Medical School, University of Texas at Austin, Austin, TX.; Han HS

Subjects: Goals* ; Immunosuppression Therapy*; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/adverse effects

  • Source: Transplantation [Transplantation] 2024 Jan 01; Vol. 108 (1), pp. 18-19. Date of Electronic Publication: 2023 Aug 01.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0132144 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  93,427 results for "%22IMMUNOSUPPRESSION%22"